Abstract
We have demonstrated that acute arginine administration decreases antioxidant defenses and compromises enzymes of respiratory chain in rat brain. In this study we evaluated in vivo and in vitro effect of arginine on pyruvate kinase activity, as well as its effect on an important parameter of oxidative stress namely thiobarbituric acid-reactive substances (TBA-RS) in cerebrum of rats. We also tested the influence of antioxidants, namely α -tocopherol plus ascorbic acid on the effects elicited by arginine in order to investigate the possible participation of free radicals on the effects of arginine on these parameters. Results showed that arginine acute administration inhibited pyruvate kinase activity in cerebrum of rats, as well as increased TBA-RS. By the other hand, arginine added to the incubation medium, in vitro studies, did not alter these parameters in rat cerebrum. In addition, pretreatment with antioxidants prevented the reduction of pyruvate kinase activity and the increase of TBA-RS caused by arginine. The data indicate that acute administration of arginine induces lipid peroxidation in rat cerebrum and that the inhibition of pyruvate kinase activity caused by this amino acid was probably mediated by free radicals since antioxidants prevented such effect. It is presumed that these results might be associated, at least in part, with the neuronal dysfunction of patients affected by hyperargininemia. Finally, we suggest that the administration of antioxidants should be considered as an adjuvant therapy to specific diets in hyperargininemia.
Similar content being viewed by others
References
Bavaresco CS, Calcagnotto T, Tagliari B, Delwing D, Lamers ML, Wannmacher CM, Wajner M, Wyse AT (2003) Brain Na+,K+-ATPase inhibition induced by arginine administration is prevented by vitamins E and C. Neurochem Res 28:825–829
Beal MF (2000) Energetics in the pathogenesis of neurodegenerative diseases. Trends Neurosci 23:298–304
Beckman JS, Carson M, Smith CD, Koppenol WH (1993) ALS. SOD and peroxynitrite. Nature 364:584
Brusilow SW, Horwich A (2001) Urea Cycle enzymes. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1909–1963
Buchmann I, Milakofsky L, Harris N, Hofford JM, Vogel WH (1996) Effect of arginine administration on plasma and brain levels of arginine and various related amino compounds in the rat. Pharmacology 53:133–142
Buettner GR (1993) The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys 300:535–543
Burton GW, Wronska U, Stone L, Foster DO, Ingold KU (1990) Biokinetics of dietary RRR-α-tocopherol in the male guinea-pig at three dietary levels of vitamin C and two levels of vitamin E. Lipids 25:199–210
Carr A, Frei B (1999) Does Vitamin C act as a pro-oxidant under physiological conditions? FASEB J 13:1007–1024
Cini M, Fariello RG, Bianchetti A, Moretti A (1994) Studies on lipid peroxidation in the rat brain. Neurochem Res 19:283–288
Darley-Usmar V, Wiseman H, Halliwell B (1995) Nitric oxide and oxygen radicals: a question of balance. FEBS Letters 369:131–135
Delwing D, Delwing D, Wannamacher CMD, Wajner M, Dutra-Filho CS, Wyse ATS (2002) Arginine administration reduces catalase activity in midbrain of rats. NeuroReport 13:1301–1304
Delwing D, Tagliari B, Streck EL, Wannamacher CMD, Wajner M, Wyse ATS (2003) Reduction of energy metabolism in rat hippocampus by aginine administration. Brain Res 983:58–63
Delwing D, Tagliari B, Chiarani F, Wannmacher CMD, Wajner M, Wyse ATS (2006) α-tocopherol and ascorbic acid administration prevents the impairment of brain energy metabolism of hyperargininemic rats. Cell Mol Neurobiol 26:177–189
Delwing D, Delwing D, Bavaresco CS, Wyse ATS (2007a) Protective effect of nitric synthase inhibition or antioxidants on brain oxidative damage caused by intracerebroventricular arginine administration. Brain Res 1193:120–127
Delwing D, Cornélio AR, Wajner M, Wannmacher CMD, Wyse ATS (2007b) Arginine administration reduces creatine kinase activity in rat cerebellum. Metab Brain Dis 22:13–23
Delwing D, Stefanello FM, Perry MLS, Wyse ATS (2007c) Inhibition of CO2 production from glucose by arginine in brain slices of rats. Metab Brain Dis 22:145–55
Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186:407–421
Feksa LR, Cornelio AR, Rech VC, Dutra-Filho CS, Wyse ATS, Wajner M, Wannmacher CMD (2002) Alanine prevents the reduction of pyruvate kinase activity in brain cortex of rats subjected to chemically induced hyperphenylalaninemia. Neurochem Res 27:947–952
Feksa LR, Cornelio AR, Vargas CR, Wyse ATS, Dutra-Filho CS, Wajner M, Wannmacher CMD (2003) Alanine prevents the inhibition of pyruvate kinase activity caused by tryptophan in cerebral cortex of rats. Metab Brain Dis 18:129–137
Feksa LR, Cornelio AR, Dutra-Filho CS, Wyse ATS, Wajner M, Wannmacher CMD (2004) Inhibition of pyruvate kinase activity by cystine in brain cortex of rats. Brain Res 1012:93–100
Floyd RA (1999) Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 222:236–245
Frei B, Stocker R, England L, Ames BN (1990) Ascorbate: the most effective antioxidant in the blood. Adv Exp Med Biol 264:155–163
Gahl WA, Thoene JG, Schneider JA (2001) Cystinosis: a disorder of lysosomal membrane transport. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic & molecular bases of inherited diseases, 8th edn. McGraw-Hill, New York, pp 5085–5108
Halliwell B, Gutteridge JMC (1985) Oxygen radicals and nervous system. Trends Neurosci 8:22–26
Halliwell B (1996) Free radicals, protein and DNA: oxidative damage versus redox regulation. Biochem Soc Trans 24:1023–1027
Halliwell B, Gutteridge JMC (1999) Oxidative stress: adaptation, damage, repair and death. In: Free radicals in biology and medicine, third ed. Oxford University Press, Oxford, pp 246–349
Iyer R, Jenkinson CP, Vockley JG, Kern RM, Grody WW, Cederbaum S (1998) The human arginases and arginase deficiency. J Inherit Metab Dis 21:86–100
Leong SF, Lai JCK, Lim L, Clark JB (1981) Energy-metabolising enzymes in brain regions of adult and aging rats. J Neurochem 37:1548–1556
Levy HL (2001) Hartnup disorder. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic & molecular bases of inherited diseases, 8th edn. McGraw-Hill, New York, pp 1667–1724
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–267
McCay PB (1985) Vitamin E: interactions with free radical and ascorbate. Annu Rev Nutr 5:323–340
Niki E (1991) Action of ascorbic acid as a scavenger of active and stable oxygen radicals. Am J Clin Nutr 54:1119S–1124S
Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358
Reis EA, Oliveira LS, Lamers ML, Netto CA, Wyse ATS (2002) Arginine administration inhibits hippocampal Na + , K + -ATPase activity and impairs retention of an inhibitory avoidance task in rats. Brain Res 951:151–157
Reznick AZ, Packer L (1993) Free radicals and antioxidants in muscular neurological diseases and disorders. In: Poli G, Albano E, Dianzani MU (eds) Free radicals: from basic science to medicine. Birkhäuser Verlag, Basel, pp 425–437
Sandy MS, DiMonte D, Smith MT (1988) Relationships between intracellular vitamin E, lipid peroxidation, and chemical toxicity in hepatocytes. Toxicol Appl Pharmacol 93:288–297
Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. N Engl J Med 336:1216–1222
Scriver CR, Kaufman S (2001) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic & molecular bases of inherited diseases, 8th edn. McGraw-Hill, New York, pp 1667–1724
Smith C, Marks AD, Lieberman M (2005) Mark’s basic medical biochemistry. Baltimore, Ed. Lippincott Williams Wilkins, 2 ed
Turpaev KT (2002) Reactive oxygen species and regulation of gene expression. Biochemistry (Mosc.) 67:281–292
Wyse ATS, Bavaresco CS, Bandinelli C, Streck EL, Franzon R, Dutra-Filho CS, Wajner M (2001) Nitric oxide synthase inhibition by L-NAME prevents the decrease of Na+, K+-ATPase activity in midbrain of rats subjected to arginine administration. Neurochem Res 26:515–520
Wyse ATS, Zugno AI, Streck EL, Matte C, Calcagnotto T, Wannmacher CMD, Wajner M (2002) Inhibition of Na+, K+-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochem Res 27:1685–1689
Wyse ATS, Stefanello FM, Chiarani F, Delwing D, Wannmacher CMD, Wajner M (2004) Arginine administration decreases cerebral cortex acetylcholinesterase and serum butyrylcholinesterase probably by oxidative stress induction. Neurochem Res 29:385–389
Yufu K, Itho T, Edamatsu R, Mori A, Hirakawa M (1993) Effect of hyperbaric oxygenation on the Na+, K+-ATPase and membrane fluidity of cerebrocortical membranes after experimental subarachnoid hemorrhage. Neurochem Res 16:1033–1039
Acknowledgements
This work was supported by grants from Universidade Regional de Blumenau—Edital interno de apoio à Pesquisa e Extensão and PMUC/FAPESC/FURB.
Author information
Authors and Affiliations
Corresponding author
Additional information
Débora Delwing and Daniela Delwing de Lima Both are first authors
Rights and permissions
About this article
Cite this article
Delwing, D., Delwing de Lima, D., Scolaro, B. et al. Protective effect of antioxidants on cerebrum oxidative damage caused by arginine on pyruvate kinase activity. Metab Brain Dis 24, 469–479 (2009). https://doi.org/10.1007/s11011-009-9152-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-009-9152-7